Clinical trial
CardioMEMS™ HF System Real-World Evidence Post-Approval Study
NCT06306573 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CardioMEMS™ HF System Real-World Evidence Post-Approval Study
- Lead sponsor
- Abbott Medical Devices
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- December 15, 2022
- Completion date
- December 31, 2029
- Enrollment
- 2,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure nyha class ii, heart failure nyha class iii